SIST EN ISO 10993-6:2026

Overview

SIST EN ISO 10993-6:2026 - Biological evaluation of medical devices - Part 6: Tests for local effects after implantation - provides internationally recognized requirements for evaluating the local biological effects of medical devices following implantation. Developed under the framework of ISO 10993, this standard is crucial for preclinical assessment to ensure safety and biocompatibility of medical devices or materials intended for use at locations where skin or mucosal tissue is breached.

This part of the ISO 10993 series applies to a wide range of device types, including solid, non-solid (porous, liquids, gels, pastes, powders, particulates), absorbable, degradable, non-absorbable, and tissue-engineered medical products (TEMPs). It is intended for use when direct contact with tissue necessitates assessment of the local biological response. Importantly, the standard outlines local tissue effects only, and does not address systemic toxicity, carcinogenicity, teratogenicity, or mutagenicity, although study designs may be adapted to examine those aspects.

Key Topics

• Scope of Application

  • Implantation test methods for devices/materials intended for use at breached tissue sites
  • Applicable to various forms and compositions of medical devices, including TEMPs
  • Focus on local effects: not designed to evaluate mechanical or functional device performance

• Study Design and Methodology

  • Emphasis on the 3 Rs principle (replace, reduce, refine animal use)
  • Adherence to animal welfare standards (ISO 10993-2)
  • Detailed preparation, sterilization, and handling procedures for test and control samples
  • Use of appropriate controls, either established biocompatible materials or compositionally similar products

• Test Methods and Assessment

  • Selection of relevant anatomical implantation site based on intended clinical use
  • Specification of sample size, test duration, and animal models
  • Guidelines for both absorbable and non-absorbable materials
  • Procedures for macroscopic and microscopic tissue evaluation
  • Recommendations for marking implantation sites and tracking degradation or absorption

• Reporting Requirements

  • Comprehensive documentation of study design, sample characteristics, animal care, and test results
  • Recording and justification of all controls, implantation periods, and observed effects

Applications

Implementation of SIST EN ISO 10993-6:2026 is critical throughout the medical device development lifecycle, especially for:

• Preclinical Safety Assessment:

  • Manufacturers use the standard to demonstrate the local biocompatibility of device materials before human clinical trials.
  • Data supports risk assessment and regulatory submissions for device approval in domestic and international markets.

• Design of Novel Devices:

  • Assists developers in selecting appropriate materials and design parameters to minimize adverse local tissue reactions.

• Regulatory Compliance:

  • Compliance with ISO 10993-6 is often required or expected by regulatory authorities, including those in the EU (Regulation (EU) 2017/745).

• Material Comparison and Improvement:

  • Enables comparative studies between new device materials and established controls with proven clinical safety.

Typical devices subject to these tests include sutures, meshes, bone substitutes, soft tissue fillers, and innovative tissue-engineered products, among others.

Related Standards

For comprehensive biological evaluation and regulatory compliance, SIST EN ISO 10993-6:2026 should be used alongside other standards in the ISO 10993 series, such as:

• ISO 10993-1: Biological evaluation - Part 1: Evaluation and testing within a risk management process
• ISO 10993-2: Animal welfare requirements
• ISO 10993-4: Selection of tests for interactions with blood
• ISO 10993-11: Tests for systemic toxicity
• ISO 10993-12: Sample preparation and reference materials
• ISO 10993-16: Toxicokinetic study design for degradation products and leachables

For specialized devices, reference may also be made to standards such as ISO 15798 (ocular devices), ISO 11979-5 (intraocular lenses), and ISO 7405 (dental materials).

Conclusion

Adhering to SIST EN ISO 10993-6:2026 ensures medical devices are evaluated for local tissue biocompatibility, supporting safe innovation and market entry. The standard is a vital tool for manufacturers, laboratories, and regulatory professionals committed to high standards of patient safety in medical device development.